Slovenia
· Delayed Price · Currency is EUR EQUINOX NEPREMICNINE d.d. Statistics
Total Valuation
EQUINOX NEPREMICNINE d.d. has a market cap or net worth of EUR 100.17 million. The enterprise value is 108.28 million.
| Market Cap | 100.17M |
| Enterprise Value | 108.28M |
Important Dates
The next estimated earnings date is Tuesday, April 15, 2025.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EQUINOX NEPREMICNINE d.d. has 1.79 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.54% |
| Owned by Institutions (%) | 18.81% |
| Float | 461,729 |
Valuation Ratios
The trailing PE ratio is 78.47.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 78.47 |
| Forward PE | n/a |
| PS Ratio | 11.79 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 84.82 |
| EV / Sales | 12.75 |
| EV / EBITDA | 24.17 |
| EV / EBIT | 240.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.12 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | n/a |
| Interest Coverage | 0.75 |
Financial Efficiency
Return on equity (ROE) is 3.24% and return on invested capital (ROIC) is 0.59%.
| Return on Equity (ROE) | 3.24% |
| Return on Assets (ROA) | 0.53% |
| Return on Capital (ROIC) | 0.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.69% in the last 52 weeks. The beta is -0.07, so EQUINOX NEPREMICNINE d.d.'s price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | +7.69% |
| 50-Day Moving Average | 57.49 |
| 200-Day Moving Average | 53.66 |
| Relative Strength Index (RSI) | 44.39 |
| Average Volume (20 Days) | 81 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EQUINOX NEPREMICNINE d.d. had revenue of EUR 8.50 million and earned 1.28 million in profits. Earnings per share was 0.71.
| Revenue | 8.50M |
| Gross Profit | 6.46M |
| Operating Income | 451,004 |
| Pretax Income | 1.55M |
| Net Income | 1.28M |
| EBITDA | 4.48M |
| EBIT | 451,004 |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 107,888 in cash and 8.22 million in debt, giving a net cash position of -8.11 million or -4.53 per share.
| Cash & Cash Equivalents | 107,888 |
| Total Debt | 8.22M |
| Net Cash | -8.11M |
| Net Cash Per Share | -4.53 |
| Equity (Book Value) | 38.82M |
| Book Value Per Share | 21.70 |
| Working Capital | 165,774 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.08%, with operating and profit margins of 5.31% and 15.03%.
| Gross Margin | 76.08% |
| Operating Margin | 5.31% |
| Pretax Margin | 18.24% |
| Profit Margin | 15.03% |
| EBITDA Margin | 52.73% |
| EBIT Margin | 5.31% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.69, which amounts to a dividend yield of 3.02%.
| Dividend Per Share | 1.69 |
| Dividend Yield | 3.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.02% |
| Earnings Yield | 1.27% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |